Altmetric – Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September

Title	Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
Published in	MMWR: Morbidity & Mortality Weekly Report, December 2022
DOI	10.15585/mmwr.mm7148e1
Pubmed ID	36454688
Authors	Ruth Link-Gelles, Allison Avrich Ciesla, Katherine E. Fleming-Dutra, Zachary R. Smith, Amadea Britton, Ryan E. Wiegand, Joseph D. Miller, Emma K. Accorsi, Stephanie J. Schrag, Jennifer R. Verani, Nong Shang, Gordana Derado, Tamara Pilishvili

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 2,506 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
United States	508	20%
Japan	201	8%
Canada	55	2%
France	38	2%
United Kingdom	27	1%
Peru	25	<1%
Australia	25	<1%
Brazil	19	<1%
Germany	13	<1%
Other	125	5%
Unknown	1470	59%

Demographic breakdown

Type	Count	As %
Members of the public	2246	90%
Scientists	116	5%
Practitioners (doctors, other healthcare professionals)	102	4%
Science communicators (journalists, bloggers, editors)	42	2%

Attention Score in Context

This research output has an Altmetric Attention Score of 3394. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2023.

All research outputs

#1,552

of 23,454,152 outputs

Outputs from MMWR: Morbidity & Mortality Weekly Report

#81

of 3,824 outputs

Outputs of similar age

#55

of 445,608 outputs

Outputs of similar age from MMWR: Morbidity & Mortality Weekly Report

of 72 outputs

Altmetric has tracked 23,454,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 3,824 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 343.0. This one has done particularly well, scoring higher than 97% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,608 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.

We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

About this Attention Score

Mentioned by

Citations

Twitter Demographics

Geographical breakdown

Demographic breakdown

Attention Score in Context